当前位置: 首页 > 期刊 > 《中国实用医药》 > 2011年第12期 > 正文
编号:12095166
急性冠脉综合征介入治疗前后血C反应蛋白变化观察(2)
http://www.100md.com 2011年4月25日 王赓 焦祺 张迎新 马娇 刘浙宁 岳丽蕾
第1页

    参见附件(2140KB,2页)。

     [3] Griscll:M,Hutchinson W I,et al. Creactice protein and complement are important mediators of tissue damage in acute in acute myocardial infarction.J EXP Med,1999,190(8):17331739.

    [4] Muclier C, buettner H I HODYSON J M,et al.Infemmation and long tem mortality after nonSTsegment elevation acute coronary syndrome treated with a very carly invasice strategy in 1042 consecatice patient circulation,2002,105(12):14121415.

    [5] 刘海波,高润霖,陈纪林,等.血清C反应蛋白对冠心病介入治疗术中及术后并发症发生的预测价值.中国循环杂志,2000,15(5):264265.

    [6] Mendall Ma,Patel P,Ballam L,et al.Reactive protein and relation to ardiovascular risk factors:a population based cross sectional study.Br Med J,1996,312(27):10611065.

    [7] Anderson IL,Carlouist JF,Muhlestein JB,et al.Evaluation of creactive protin,and inflammatory marker,and infections serology as fisk factors for coronary artery disease and myocardial infection.J Am coll cardiol,1998,32(1):3541.

    [8] Ridker PM,Cushman M,Stampfer MJ,et al.Inflammation,aspirin,and the risk of cardiovascular disease in apparently healthy men.N EngL J Med,1996,336:973.

    [9] Ridker PM,Hennekens CH,Buring JE,et al.Creactive protein and othermarkers of inflammation in the prediction of cardiovascular disease in women.N Engl J Med,2000,342(12):836843.

您现在查看是摘要介绍页,详见PDF附件(2140KB,2页)